test

adam-persiani

Adam Persiani

investor-logo-pharos

300_300_investor_dxpx_us_2022_photo Alex Efron

Alex Efron

300_90_investor_dxpx_us_2022_logoAlex Efron THP

300_300_investor_dxpx_us_2022_photo bernice welles ipf

Bernice Welles

300_90_investor_dxpx_us_2022_logo ipf partners

Boris Pevzner

Boris Pevzner

investor-logo-gg-global-counsel

Christina Escoda

Christina Escoda

300_90_investor_dxpx_us_2022_logotachyon

Eric Fritz

Eric Fritz

MVM Partners

300_300_investor_dxpx_us_2022_photoeric edp

Eric Mayer

300_90_investor_dxpx_us_2022_logoedp

Helena Gittelman

Helena Gittelman

nrw-global-business

Jordan Brown

Jordan Brown

1315 Capital

Julianne Roseman

Julianne Roseman

300_90_investor_dxpx_us_2022_logo plug n play

300_300_investor_dxpx_us_2022_photo_kaipeng_xia

Kaipeng Xia

300_90_investor_dxpx_us_2022_logo citi cifh

300_300_investor_dxpx_us_2022_photo kelyl depont probipas

Kelly DePonte

300_90_investor_dxpx_us_2022_logo probitas

Kenneth Brown

Kenneth Brown

Lionchase

Kevin McNeil

Kevin McNeil

investor logo avego

300_300_investor_dxpx_us_2022_photo_khalil_maalouf

Khalif Maalouf

300_90_investor_dxpx_us_2022_logo_xpv

Kyle Dempsey

Kyle Dempsey

MVM Partners

Mark Raterman

Mark Raterman

LNC Partners

Martin O’Shield

Martin O’Shield

300_90_investor_dxpx_us_2022_logo windycitysdr

300_300_investor_dxpx_us_2022_photomichael hong

Michael Hong

300_90_investor_dxpx_us_2022_logo sgi

Michele Colucci

Michele Colucci

DigitalDx-Ventures

Nihar Prasanna

Nihar Prasanna

300_90_investor_dxpx_us_2022_logo werfen

Peter Blaney

Peter Blaney

investor logo induran

300_300_investor_dxpx_us_2022_photo_peter_mintun

Peter Mintun

Peter Savas

Peter Savas

300_90_investor_dxpx_us_2022_logo agp ventures

phil lavin

Phil Lavin

300_90_investor_dxpx_us_2022_logo_meliocm

Reetika Bhardwaj

Reetika Bhardwaj

investor logo arche venture partners

Richie Bavasso

Richie Bavasso

investor-logo-nq-medical

300_300_investor_dxpx_us_2022_photo robert granier

Roberto Granier

300_90_investor_dxpx_us_2022_logo general fluidics

Sameer Rohatgi

Sameer Rohatgi

lyfe capital

300_300_investor_dxpx_us_2022_photo lavin

Sean Lavin

300_90_investor_dxpx_us_2022_logo alpha lavin

Sebastien Latapie

Sebastien Latapie

300_90_investor_dxpx_us_2022_logo_dynamk_capital

Silvia Restelli

Silvia Restelli

investor-logo-astia

Smit Savani

Smit Savani

investor logo avego

300_300_investor_dxpx_us_2022_photo vickram genoa

Vikhram Chaudhery

300_90_investor_dxpx_us_2022_logo genoa vickram

300_300_investor_dxpx_us_2022_photo_william_bill_hyun_genoa

William (Bill) Hyun

genoa

William Podd

William Podd

landmark angels

no picture yet

Yash Modi

investor logo business angel

Yuki Furuta

Yuki Furuta

investor logo tosoh

Oliver Dick

Oliver brings 30+ years of experience in the life sciences industry, has worked in pharma, biotechnology and in vitro diagnostics. His areas of expertise fall under Supply Chain Management, Planning, Production, QC, QA, Engineering, Technology Transfer and Process Improvement. Amongst his vast experience, Oliver held functions such as Vice President of Global Manufacturing at QIAGEN, Chief Operating Officer at Miltenyi Biotec or Chief Operating Office of Resolve Biosciences. He demonstrated exceptional leadership and expertise in driving manufacturing excellence on a global scale.

Oliver has a proven ability to streamline processes, optimize production efficiency, and foster a culture of innovation. He was responsible for strategy development, scaling, cost control and quality and was part of multiple M&A projects and transfer of many new products from acquisition or own development. Today Oliver offers his expertise mainly through his own Consultancy Service Company ODICON.

Experience

Christoph Brandenberger is a Managing Director at BGL and a leader in the firm’s Diagnostics, Research Tools & Medical Devices investment banking group. He has more than 20 years of experience in all aspects of mergers and acquisitions, commercialization and partnering agreements, and private placements.

A native of Austria and fluent in German, Christoph’s investment banking experience, coupled with his background in international business, has made him a sought-after advisor in both the domestic and international healthcare markets.

Prior to joining BGL, Christoph served as managing director for Healthios Capital Markets, LLC. Christoph started his career as a financial analyst for Bank of America Securities.

Experience

John Riddle

John Riddle is a Managing Director and member of the BGL Executive Committee. He has more than 30 years of investment banking and capital markets experience, advising clients across a broad spectrum of mergers and acquisitions, capital markets activities, and strategic assignments.

John leads BGL’s advisory activities in the Healthcare & Life Sciences investment banking group, which comprises both corporate investment banking and real estate capital markets capabilities. Together with his team, John maintains an ongoing coverage effort with broad activity across several sectors, including health facilities, physician services, and ancillary providers; diagnostics and research tools; medical device and products; and select healthcare technology verticals, including payor services, data analytics, and clinical automation.

Experience

Dr. Mirko Stange

Born in Bremen, Germany in 1974, Dr. Mirko Stange is a diagnostics and life sciences expert with a proven track record in turning around and commercializing innovations. He possesses extensive executive management experience, having led diagnostics and biotech startups, as well as developing and conducting consulting products. Following the completion of his Ph.D. in Biochemistry and Biophysics at the University of North Carolina at Chapel Hill, Dr. Stange began his career in 2004 at the strategy consultancy McKinsey. Subsequently, he worked with the turnaround-specialized advisory firm Droege & Comp., primarily serving clients from the pharma and chemistry industry in Germany and Switzerland.

In 2008, he founded an independent Life Sciences consultancy in Germany where, to date, he leads and directs a team of international experts. This team identifies and funds SMEs with high potential for national and international leverage. In addition to his over ten years of experience in independent corporate finance and management consulting, Mirko Stange provides interim management services to selected clients. To date, three companies co-founded and managed/advised by Dr. Stange have been successfully exited. Leveraging his scientific background, he is also a named inventor on several granted and pending patents.

Experience

FName LName

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Experience